Does RISANKIZUMAB-RZAA Cause Device defective? 26 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Device defective have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
26
Reports of Device defective with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
6
Hospitalizations
How Dangerous Is Device defective From RISANKIZUMAB-RZAA?
Of the 26 reports, 6 (23.1%) required hospitalization.
Is Device defective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Device defective?
SOMATROPIN (1,719)
USTEKINUMAB (1,071)
SECUKINUMAB (666)
GUSELKUMAB (574)
GOLIMUMAB (539)
ABATACEPT (458)
ALBUTEROL (445)
TOCILIZUMAB (400)
INSULIN GLARGINE (397)
EXENATIDE (387)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Device defective Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA